XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
  Arthritis
   Ankylosing Spondylitis
   Rheumatiod Arthritis
   Osteoarthritis
  Scleroderma
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
 
 India
Search

Last Updated: Nov 18, 2006 - 12:32:53 PM

Arthritis Channel
subscribe to Arthritis newsletter

Latest Research : Rheumatology : Arthritis

   DISCUSS   |   EMAIL   |   PRINT
Brightly-coloured fruit and veg may protect against arthritis
Aug 18, 2005 - 2:17:00 AM, Reviewed by: Dr.

"Those in the top third for beta-cryptoxanthin intake were only half as likely to develop IP as those in the lowest third, and vitamin C was also found to be an important factor."

 
Researchers from The University of Manchester's Medical School have discovered that eating more brightly-coloured fruits and vegetables like oranges, carrots and sweetcorn may help reduce the risk of developing inflammatory disorders like rheumatoid arthritis.

Rheumatoid arthritis currently affects around 1% adults in the UK. Previous studies have suggested that vitamin C and the pigment beta-cryptoxanthin, both of which are found in brightly-coloured fruit and veg, may act as antioxidants, and protect the body against the oxidative damage which can cause inflammation.

The Manchester team, based in the Arthritis Research Campaign's Epidemiology Unit, worked with researchers from the Institute of Public Health at the University of Cambridge to analyse health questionnaires and diet diaries by over 25000 45-74 year-olds; completed as part of the EPIC (European Prospective Investigation of Cancer) Norfolk study of diet and chronic disease in the 1990s. They then followed-up the participants over a nine year period to identify new cases of inflammatory polyarthritis (IP), including rheumatoid arthritis.

Dr Dorothy Pattison, who led the research, said: "We found that the average daily beta-cryptoxanthin intake of the 88 patients who had developed inflammatory polyarthritis was 40% lower than those who hadn't, and their intake of another carotenoid, zeaxanthin, was 20% lower.

"Those in the top third for beta-cryptoxanthin intake were only half as likely to develop IP as those in the lowest third, and vitamin C was also found to be an important factor."

The findings appear to confirm previous evidence that a modest increase in fruit and vegetables containing beta-cryptoxanthin and vitamin C, equivalent to one glass of freshly-squeezed orange juice each day, might help to protect against developing inflammatory joint diseases.

Dr Pattison has previously published research which found that both low intakes of fruit and vegetables (in particular those high in vitamin C), and high levels of red meat consumption were associated with an increased risk of developing IP.
 

- August issue of The American Journal of Clinical Nutrition
 

University of Manchester

 
Subscribe to Arthritis Newsletter
E-mail Address:

 

A full paper on the findings of the research appears in the August issue of The American Journal of Clinical Nutrition (http://www.ajcn.org/current.shtml).

The EPIC Norfolk study is funded by the Medical Research Council, Cancer Research UK and the British Heart Foundation.

The University of Manchester (www.manchester.ac.uk) was formed by the merger of The Victoria University of Manchester and UMIST in October 2004, and with 36 000 students expected in the coming academic year is the largest higher education institution in the country. Its Faculty of Medical & Human Sciences (www.mhs.manchester.ac.uk) is one of the largest faculties of clinical and health sciences in Europe, with a research income of over �37 million.

The School of Medicine (www.medicine.manchester.ac.uk) is the largest of the Faculty's five Schools, with 1300 staff, almost 2000 undergraduates and a �32M research income. The School encompasses five teaching hospitals, and is closely linked to a range of general hospitals and community practices across the North West of England.

For further information please contact:

Jo Nightingale on 0161 275 8156/[email protected], or Mikaela Sitford on 0161 275 2111/[email protected].

The Arthritis Research Campaign (arc) is the fourth largest medical research charity in the UK, funding research totalling �20 million annually. For more information please contact arc press officer Jane Tadman on 01246 541107 or visit www.arc.org.uk.

The University of Cambridge's (www.cam.ac.uk) reputation for outstanding academic achievement is known worldwide and reflects the intellectual achievement of its students as well as the world-class original research carried out by the staff of the University and the Colleges.

As Cambridge approaches its 800th anniversary in 2009, it continues to change in response to the challenges it faces. The modern University is an international centre of teaching and research in a vast range of subjects: about half of the students study science or technology. Members of the University have won over 80 Nobel Prizes.


Related Arthritis News

Matrilin-3 gene discovered to prevent onset of osteoarthritis
Rituximab halts damage to joints
Tocilizumab effective in systemic juvenile idiopathic arthritis (sJIA)
Unfavourable blood fat levels predict rheumatoid arthritis up to 10 years later
Role of inflammatory leukocytes in extending tissue damage
Rituximab achieves remission in patients resistant to conventional DMARDs
New hope for tissue regeneration and joint repair
Fighting inflammation with targeted liposomal therapy
Snake venom could ease arthritis pain
Sodium Hyaluronate Can Fill the gap left by Cox-2 inhibitors


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us